Precigen, Inc. (PGEN) Q1 FY26 Earnings Call

Launch revenue accelerated sharply, but Q1 operating cash use was substantial and patient-conversion trends remain unquantified.

Q1 FY26 results, source: company transcript and SEC filings
QuarterQ1 FY26
Call date2026-05-15
Length32 minutes
EPS$-0.02
EPS consensus$-0.03
Revenue$23.3M
Revenue consensus$20.8M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Read the full Q1 FY26 earnings call transcript

All PGEN earnings ยท Back to PGEN overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.